Woodward D F, Wasserman M A, Weichman B M
Eur J Pharmacol. 1983 Sep 16;93(1-2):9-19. doi: 10.1016/0014-2999(83)90025-0.
A direct comparison of the role of leukotrienes in mediating the increase in microvascular permeability associated with guinea pig tracheal and cutaneous anaphylaxis was obtained by simultaneous administration of inflammatory stimuli to both trachea and ear. The SRS-A antagonist, FPL 55712, reduced the increase in tracheal extravascular albumin content evoked by LTC4, LTD4, and LTE4 but failed to significantly reduce the tracheal microvascular permeability response associated with local anaphylaxis. Moreover, the inhibitory effect of the histamine H1-receptor antagonist, mepyramine, was not augmented by the additional presence of FPL 55712. In contrast to tracheal anaphylaxis, a distinct leukotriene component was indicated in cutaneous anaphylaxis since the mepyramine-FPL 55712 combination produced a greater inhibition than mepyramine alone. These results suggest that the degree of leukotriene involvement in anaphylaxis may vary between tissues.
通过同时对豚鼠气管和耳部施加炎性刺激,直接比较了白三烯在介导与豚鼠气管和皮肤过敏反应相关的微血管通透性增加中的作用。SRS-A拮抗剂FPL 55712可降低LTC4、LTD4和LTE4引起的气管血管外白蛋白含量增加,但未能显著降低与局部过敏反应相关的气管微血管通透性反应。此外,组胺H1受体拮抗剂美吡拉敏的抑制作用并未因额外存在FPL 55712而增强。与气管过敏反应不同,皮肤过敏反应中显示出明显的白三烯成分,因为美吡拉敏-FPL 55712组合比单独使用美吡拉敏产生更大的抑制作用。这些结果表明,白三烯参与过敏反应的程度在不同组织之间可能有所不同。